
Sign up to save your podcasts
Or


Businesses have reopened and most schools have come up with plans to see students again, but it’s increasingly clear life won’t truly get back to “normal” until we have a vaccine.
But when will that be? This hour, we get the latest from New York Times science writer Carl Zimmer on the race to develop a COVID vaccine. We hear the status of ongoing vaccine trials and learn more about the research process that ensures a vaccine will be safe and effective.
Later, we talk about navigating the confusing world of health care in a pandemic with a reporter from Kaiser Health News. Connecticut’s Healthcare Advocate also joins us to help answer the complicated questions around health insurance and how this crisis may shape conversations about the future of US health care.
GUESTS:
Support the show: http://wnpr.org/donate
See omnystudio.com/listener for privacy information.
By Connecticut Public Radio4.2
5656 ratings
Businesses have reopened and most schools have come up with plans to see students again, but it’s increasingly clear life won’t truly get back to “normal” until we have a vaccine.
But when will that be? This hour, we get the latest from New York Times science writer Carl Zimmer on the race to develop a COVID vaccine. We hear the status of ongoing vaccine trials and learn more about the research process that ensures a vaccine will be safe and effective.
Later, we talk about navigating the confusing world of health care in a pandemic with a reporter from Kaiser Health News. Connecticut’s Healthcare Advocate also joins us to help answer the complicated questions around health insurance and how this crisis may shape conversations about the future of US health care.
GUESTS:
Support the show: http://wnpr.org/donate
See omnystudio.com/listener for privacy information.

91,012 Listeners

38,476 Listeners

6,763 Listeners

43,712 Listeners

38,686 Listeners

9,187 Listeners

3,968 Listeners

58 Listeners

6,364 Listeners

342 Listeners

14,636 Listeners

112,758 Listeners

13 Listeners

3 Listeners

16,239 Listeners

46 Listeners

96 Listeners

18 Listeners

2 Listeners

0 Listeners

79 Listeners

29 Listeners

24 Listeners

16,042 Listeners

0 Listeners

9 Listeners

21 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners

44 Listeners

598 Listeners